PeerMedical

Company Overview

Snapshot

Founded in January 2009, PeerMedical operated with 201–500 employees. The company was acquired by EndoChoice in February 2013.

Business overview

PeerMedical develops innovative medical devices for the endoscopy arena, focusing on diagnostic devices for the gastrointestinal system. Its core product is an endoscope designed to diagnose gastrointestinal polyps, offering a broader view of the bowel compared to traditional colonoscopy. The company serves the healthcare industry, specifically targeting providers within the Health Tech & Life Sciences sector with its diagnostic imaging technology.

Strategic signal

In January 2013, PeerMedical announced its merger with EndoChoice. This strategic move signaled a significant consolidation in the medical device sector, allowing PeerMedical's diagnostic endoscopy technology to integrate into a larger platform, potentially accelerating market reach and product development under a new corporate structure.

Company Intelligence Q&A

When was PeerMedical acquired?

PeerMedical was acquired by EndoChoice in February 2013.

What was a key strategic event for PeerMedical in early 2013?

In January 2013, PeerMedical merged with EndoChoice, a significant event for the company.

What type of product does PeerMedical develop?

PeerMedical develops an endoscope for diagnosing gastrointestinal polyps, which can lead to bowel cancer.

What is PeerMedical's primary focus in the medical device sector?

PeerMedical focuses on innovative medical devices in the endoscopy arena, utilizing proprietary and patented technologies for gastrointestinal diagnostics.

Which investor participated in a funding round for PeerMedical?

Accelmed participated as a lead investor in a funding round for PeerMedical in November 2010.